- Home
- ACHL
as 07-26-2024 4:00pm EST
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
| Founded: | 2016 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 38.2M | IPO Year: | 2021 |
| Target Price: | $2.83 | AVG Volume (30 days): | 37.6K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.74 - $1.76 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Achilles Therapeutics plc News
ACHL Breaking Stock News: Dive into ACHL Ticker-Specific Updates for Smart Investing
PR Newswire
2 months ago
Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than
PR Newswire
2 months ago
3 Major Product Releases at 3Shape Discover Event
Business Wire
2 months ago
Net Asset Value(s)
AFP
2 months ago
Irish, Czechs hold EU vote after Dutch far-right gains
Motley Fool
2 months ago
Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock
GlobeNewswire
2 months ago
GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials
![[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](https://cdn.finquota.com/news/d47e9257-eb69-499e-bcb2-2836f3b04190.png)
GlobeNewswire
2 months ago
[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
PR Newswire
2 months ago
Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation
Compare ACHL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACHL Achilles Therapeutics plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.